{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:26:52Z","timestamp":1789518412296,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.lungcan.2024.107540","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T18:00:19Z","timestamp":1711303219000},"page":"107540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-8915","authenticated-orcid":false,"given":"Takehiro","family":"Tozuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-4138","authenticated-orcid":false,"given":"Rintaro","family":"Noro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Kurimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9980-4417","authenticated-orcid":false,"given":"Taiki","family":"Hakozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakeru","family":"Hisakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0733-6094","authenticated-orcid":false,"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1897-5933","authenticated-orcid":false,"given":"Namiko","family":"Taniuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-5905","authenticated-orcid":false,"given":"Yukio","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Minegishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9649-9130","authenticated-orcid":false,"given":"Tetsuya","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-9548","authenticated-orcid":false,"given":"Koichiro","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-5472","authenticated-orcid":false,"given":"Masahiro","family":"Seike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2024.107540_b0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"2004","key":"10.1016\/j.lungcan.2024.107540_b0010","first-page":"2865","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system","volume":"22","author":"Barnholtz-Sloan","year":"1973","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/cncr.23826","article-title":"Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma","volume":"113","author":"Saad","year":"2008","journal-title":"Cancer."},{"key":"10.1016\/j.lungcan.2024.107540_b0020","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U","article-title":"Brain metastases. Histology, Multiplicity, Surgery, and Survival","volume":"78","author":"Nussbaum","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2024.107540_b0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2016.03.009","article-title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","volume":"45","author":"Peters","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2024.107540_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","article-title":"EGFR mutation and brain metastasis in pulmonary adenocarcinomas","volume":"9","author":"Shin","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0035","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"North-East Japan study group, gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107540_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"FLAURA investigators, Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107540_b0045","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/1078-0432.CCR-16-0399","article-title":"Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity","volume":"22","author":"Ballard","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107540_b0050","first-page":"27","article-title":"Strategies to improve delivery of anticancer drugs across the blood\u2013brain barrier to treat glioblastoma, neuro","volume":"18","author":"Oberoi","year":"2016","journal-title":"Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0055","doi-asserted-by":"crossref","unstructured":"T. Reungwetwattana, K. Nakagawa, B.C. Cho, M. Cobo, E.K. Cho, A. Bertolini, S. Bohnet, C. Zhou, K.H. Lee, N. Nogami, I. Okamoto, N. Leighl, R. Hodge, A. McKeown, A.P. Brown, Y. Rukazenkov, S.S. Ramalingam, J. Vansteenkiste, CNS response to Osimertinib versus Standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer, J. Clin. Oncol. (2018) JCO2018783118. https:\/\/doi.org\/10.1200\/JCO.2018.78.3118.","DOI":"10.1200\/JCO.2018.78.3118"},{"key":"10.1016\/j.lungcan.2024.107540_b0060","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"ADAURA investigators, Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107540_b0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.410070606","article-title":"Radiation therapy for brain metastases","volume":"7","author":"Cairncross","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lungcan.2024.107540_b0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.radonc.2011.01.011","article-title":"Dose-effect relation in stereotactic radiotherapy for brain metastases. a systematic review","volume":"98","author":"Wiggenraad","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0080","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107540_b0085","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","article-title":"Management of brain metastases in tyrosine kinase inhibitor-na\u00efve epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis","volume":"35","author":"Magnuson","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"Supplement 1","key":"10.1016\/j.lungcan.2024.107540_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/2016.7.GKS161499","article-title":"Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases","volume":"125","author":"Lester-Coll","year":"2016","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.lungcan.2024.107540_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0100","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ijrobp.2015.07.2280","article-title":"Leukoencephalopathy after stereotactic radiosurgery for brain metastases","volume":"93","author":"Trifiletti","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107540_b0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3171\/jns.1996.84.5.0748","article-title":"Surgery versus radiosurgery in the treatment of brain metastasis","volume":"84","author":"Bindal","year":"1996","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.lungcan.2024.107540_b0110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology."},{"key":"10.1016\/j.lungcan.2024.107540_b0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lungcan.2024.107540_b0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41416-020-01128-5","article-title":"Metastasis-directed therapy for oligometastasis and beyond","volume":"124","author":"Beckham","year":"2021","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.lungcan.2024.107540_b0125","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jtho.2019.05.025","article-title":"Beyond palliation: the rationale for metastasis-directed therapy for metastatic non-small cell lung cancer","volume":"14","author":"Foster","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0130","doi-asserted-by":"crossref","first-page":"90ra59","DOI":"10.1126\/scitranslmed.3002356","article-title":"Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling","volume":"3","author":"Chmielecki","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2024.107540_b0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cllc.2012.10.007","article-title":"Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib","volume":"14","author":"Park","year":"2013","journal-title":"Clin. Lung Cancer."},{"key":"10.1016\/j.lungcan.2024.107540_b0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0360-3016(80)90195-9","article-title":"The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group","volume":"6","author":"Borgelt","year":"1980","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107540_b0150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0155","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA."},{"key":"10.1016\/j.lungcan.2024.107540_b0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jtho.2021.08.009","article-title":"Brain metastases in EGFR- and ALK-positive NSCLC: outcomes of central nervous system-penetrant tyrosine kinase inhibitors alone versus in combination with radiation","volume":"17","author":"Thomas","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2014.12.011","article-title":"EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis","volume":"114","author":"Soon","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0170","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1158\/0008-5472.CAN-06-2627","article-title":"Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation","volume":"66","author":"Das","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107540_b0175","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1158\/0008-5472.CAN-04-3547","article-title":"Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)","volume":"65","author":"Chinnaiyan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107540_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lungcan.2021.02.036","article-title":"Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer","volume":"155","author":"Moraes","year":"2021","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2024.107540_b0185","first-page":"660","article-title":"Genes that mediate metastasis across the blood\u2013brain barrier, trends","volume":"6","author":"Fares","year":"2020","journal-title":"Cancer."},{"key":"10.1016\/j.lungcan.2024.107540_b0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijrobp.2005.01.039","article-title":"Molecular targets in radiation-induced blood\u2013brain barrier disruption","volume":"62","author":"Nordal","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107540_b0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2018.03.013","article-title":"Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: a retrospective analysis of 133 consecutive patients","volume":"119","author":"Yomo","year":"2018","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2024.107540_b0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0205","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0210","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0215","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","article-title":"FLAURA2 investigators, Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC","volume":"389","author":"Planchard","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107540_b0220","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.23.02219","article-title":"CNS efficacy of osimertinib with or without chemotherapy in epidermal growth factor receptor-mutated advanced non-small-cell lung cancer","volume":"42","author":"J\u00e4nne","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107540_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102291","article-title":"Brain metastases in patients with oncogenic-driven non-small cell lung cancer: pros and cons for early radiotherapy","volume":"100","author":"Lee","year":"2021","journal-title":"Cancer Treat. Rev."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T18:33:13Z","timestamp":1715625193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224000734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":45,"alternative-id":["S0169500224000734"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107540","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107540"}}